Skip to main content

Table 1 Clinical characteristics of participants (mean ± S.D.)

From: Regional homogeneity changes between heroin relapse and non-relapse patients under methadone maintenance treatment: a resting-state fMRI study

Characteristics

Non-relapse (N =19)

Relapse (N = 21)

T-value

p-value

Age (years)

39.3 ± 7.1

35.6 ± 5.4

1.74

0.09

Education level (years)

9.1 ± 2.6

9.5 ± 2.2

−0.49

0.62

Cigarettes (per day)

21 ± 8.5

21.3 ± 10.1

−0.12

0.90

Duration of cigarette smoking (months)

275.7 ± 69.1

224 ± 64.5

2.29

0.30

Daily dosage of heroin abuse (g)

0.3 ± 0.2

0.3 ± 0.1

0.16

0.87

Accumulated dosage of heroin abuse (g)

1036.8 ± 1232.2

918.8 ± 1186.9

0.28

0.77

Duration of heroin abuse (months)

275.7 ± 69.1

224 ± 64.5

0.49

0.62

Accumulated dosage of methadone use (l)

41.6 ± 34.9

30.6 ± 17.4

1.16

0.25

Daily dosage of methadone use (ml)

44.1 ± 19.5

43.5 ± 11.8

0.11

0.91

  1. Note: Unless otherwise indicated, data are means ± standard deviations (S.D.)